Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome

Fertility and Sterility

Volumn 78, Issue 3, 2002, Pages 479-486

  Remsberg, Karen E ^a   Talbott, Evelyn O ^a   Zborowski, Jeanne V ^a   Evans, Rhobert W ^a   McHugh Pemu, Kathleen ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Androgen excess; Body composition; Fat mass; Fertility; Hyperinsulinemia; Insulin resistance; Leptin; Polycystic ovary syndrome; Reproduction

Indexed keywords

INSULIN; LEPTIN;

ADIPOCYTE; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ADULT; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LEPTIN; OBESITY; PENNSYLVANIA; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES; REPRODUCTION; THINNESS;

EID: 0036732168     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03303-4     Document Type: Article

References (42)

1. Leptin and the regulation of body weight in mammals
2. Sympathetic activation of leptin via the ventromedial hypothalamus; leptin-induced increase in catecholamine secretion
3. Leptin
4. Leptin; fundamental aspects
5. Contribution of androgens to the gender difference in leptin production in obese children and adolescents
6. Serum leptin concentration, body composition, and gonadal hormones during puberty
7. Serum leptin levels during childhood and adolescence; relationship with age, sex, adiposity and puberty
8. Cardiovascular consequences of obesity; role of leptin
9. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats
10. Decreased central and peripheral catecholaminergic activation in obese Zucker rats
11. Transient increase in obese gene expression after food intake or insulin administration
12. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men
13. Dehydroepiandrosterone (DHEA) administration reduces serum leptin in obese postmenopausal women
14. Effects of gender, body composition, and menopause on plasma concentrations of leptin
15. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome
16. Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome
17. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome
18. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism; influence on LH and relationship with hormonal, metabolic, and anthropometric measurements
19. Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women
20. Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide
21. Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome
22. Leptin concentrations in the polycystic ovary syndrome
23. Serum leptin concentrations in women with polycystic ovary syndrome
24. Serum leptin levels in women with polycystic ovary syndrome; the role of insulin resistance/hyperinsulinemia
25. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
26. Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients
27. Coronary heart disease risk factors in women with polycystic ovary syndrome
28. Bone mineral density among women with polycystic ovary syndrome
29. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum
30. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
31. Assessment of body fat; a comparison of techniques
32. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo
33. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome; results of a case-control study
34. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women
35. Circulating leptin concentrations in polycystic ovary syndrome; relation to anthropometric and metabolic parameters
36. Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans
37. Bone mineral density and body composition in lean women with polycystic ovary syndrome
38. Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids
39. Circulating leptin levels during ovulation induction; relation to adiposity and ovarian morphology
40. Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome
41. Plasma leptin levels in healthy children and adolescents; dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone
42. Serum leptin levels in normal children; relationship to age, gender, body mass index, body fat mass, gender, pubertal stage, and testosterone